Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Quinkler

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenomaFabio Luiz Fernandes-Rosa, Tracy Ann Williams, Anna Riester, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2015
Pregnancy in Women Previously Treated for an Adrenocortical CarcinomaPauline de Corbière, Katrin Ritzel, Laure Cazabat, et al.
European Journal of Endocrinology|January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasiaLea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2014
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomySilvia Monticone, Fumitoshi Satoh, Andrea Viola, et al.
The Lancet. Diabetes & Endocrinology|June 4, 2017
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohortTracy A Williams, Jacques W M Lenders, Paolo Mulatero, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing AdenomaBritta Heinze, Carmina T Fuss, Paolo Mulatero, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2020
Residual Corticosteroid Production in Autoimmune Addison DiseaseÅse Bjorvatn Sævik, Anna-Karin Åkerman, Paal Methlie, et al.
The Journal of Clinical Endocrinology and Metabolism|January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resectionFelix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Hypertension (Dallas, Tex. : 1979)|May 29, 2014
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenomaFabio Luiz Fernandes-Rosa, Tracy Ann Williams, Anna Riester, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2015
Pregnancy in Women Previously Treated for an Adrenocortical CarcinomaPauline de Corbière, Katrin Ritzel, Laure Cazabat, et al.
European Journal of Endocrinology|January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasiaLea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2014
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomySilvia Monticone, Fumitoshi Satoh, Andrea Viola, et al.
The Lancet. Diabetes & Endocrinology|June 4, 2017
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohortTracy A Williams, Jacques W M Lenders, Paolo Mulatero, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing AdenomaBritta Heinze, Carmina T Fuss, Paolo Mulatero, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2020
Residual Corticosteroid Production in Autoimmune Addison DiseaseÅse Bjorvatn Sævik, Anna-Karin Åkerman, Paal Methlie, et al.
The Journal of Clinical Endocrinology and Metabolism|January 7, 2015
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resectionFelix Beuschlein, Jens Weigel, Wolfgang Saeger, et al.
Pageof 21